Hemofix (DrugBank: -)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
288 | 自己免疫性後天性凝固因子欠乏症[自己免疫性出血病XIII (~2017.3)] | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01651468 (ClinicalTrials.gov) | September 2016 | 25/7/2012 | The Effect of the Nutraceutical Hemofix on the Coagulation System | Phase 1 Study of the Nutraceutical Hemofix Safety and Effect on the Coagulation System | Von Willebrand Disease;Menorrhagia | Dietary Supplement: HEMOFIX | Hadassah Medical Organization | HEMOFIX;Yocheved Grossman;Idan Grossman | Withdrawn | 18 Years | 75 Years | All | 0 | Phase 1 | Israel |